Animal Diagnostics Market

• Animal diagnostics market was valued at USD 3.1 billion in 2024 and is projected to reach USD 7.5 billion by 2034, growing at a CAGR of 9.2% from 2025 to 2034.

• Consumables led the market in 2024, accounting for USD 2.6 billion in revenue, driven by their frequent use in routine testing procedures.

• North America dominated the global market with a 40.9% share in 2024, attributed to high pet ownership rates and advanced veterinary infrastructure.

• Companion animals accounted for the largest share of the market, with dogs being the most prevalent species requiring diagnostic services.

• Molecular diagnostics held the highest market share in 2023, offering precise and rapid detection of diseases at the genetic level.

• Point-of-care diagnostics are gaining popularity, enabling veterinarians to perform tests and receive results promptly, enhancing treatment efficiency.

• Technological advancements such as AI-powered diagnostic tools and portable diagnostic devices are enhancing the accuracy and accessibility of veterinary diagnostics.

• In August 2022, PepiPets launched a mobile diagnostic testing service, enabling clients to conduct at-home pet diagnostics. This service aims to make procedures more comfortable for pets while saving time on visits to a veterinary office.

• In March 2022, Companion Animal Health entered a strategic agreement and made an equity investment in HT BioImaging to co-brand and exclusively sell the HTVet product in North America.

In this report,The Animal Diagnostics Market has been segmented by Product, Technology, Animal Type and Geography.

Animal Diagnostics Market, Segmentation by Product

The Animal Diagnostics Market has been segmented by Product into Growing trend of adopting pet animals, Rising Prevalence of Food Borne and Zoonotic Diseases, Favorable Government Initiatives, Rapidly Increasing Demand for Animal Products and Advancements in Veterinary Diagnostics.

Growing Trend of Adopting Pet Animals
The growing trend of pet adoption contributes to nearly 28% of the animal diagnostics market. Rising pet humanization, especially in urban areas, has led to increased spending on veterinary healthcare and diagnostics. Pet owners are increasingly opting for preventive screenings and routine diagnostic tests to ensure animal well-being.

Rising Prevalence of Food Borne and Zoonotic Diseases
This segment holds around 24% of the market due to the global concern over zoonotic infections such as salmonellosis, brucellosis, and avian influenza. The growing focus on food safety and animal-to-human disease transmission is increasing the demand for rapid and accurate diagnostic tools in both livestock and companion animals.

Favorable Government Initiatives
Government initiatives contribute to approximately 18% of the market. Regulatory bodies across regions are supporting animal health programs, promoting mass vaccination drives, and investing in epidemiological surveillance. These efforts are boosting the adoption of diagnostic kits for early disease detection and control.

Rapidly Increasing Demand for Animal Products
This segment accounts for around 20% of the market, driven by the rising global demand for milk, meat, and eggs. Healthy livestock is essential for ensuring productivity and safety, which is increasing the reliance on diagnostic solutions for early identification of infectious and metabolic diseases.

Advancements in Veterinary Diagnostics
Technological advancements make up about 10% of the market, with innovations such as molecular diagnostics, point-of-care testing, and next-generation sequencing. These tools enable quick and precise diagnosis of complex animal diseases, enhancing treatment outcomes and reducing the risk of outbreaks.

Animal Diagnostics Market, Segmentation by Technology

The Animal Diagnostics Market has been segmented by Technology into Immunodiagnostics - ELISA, Lateral flow assays, Immunoassay analyzers and Others, Clinical biochemistry, Hematology and Molecular diagnostics - PCR, Microarrays and Others, Urinalysis, Others and Ambulatory surgical centers.

Immunodiagnostics – ELISA, Lateral Flow Assays, Immunoassay Analyzers and Others
Immunodiagnostics dominate the market, accounting for approximately 35% of the technology segment. Tools like ELISA and lateral flow assays are widely used for the detection of antigens and antibodies in companion and livestock animals. The high sensitivity, specificity, and ease of use contribute to their extensive adoption.

Clinical Biochemistry
Clinical biochemistry holds about 20% of the market and plays a vital role in evaluating organ function and metabolic conditions in animals. This includes analyzing electrolytes, enzymes, and biomarkers from blood and serum samples to support diagnosis and treatment planning.

Hematology
Hematology contributes approximately 15% of the market. It focuses on the quantitative and qualitative analysis of blood components such as RBCs, WBCs, and platelets. This method is critical for identifying infections, anemia, and immune responses in both domestic and farm animals.

Molecular Diagnostics – PCR, Microarrays and Others
Molecular diagnostics represent nearly 18% of the market and are rapidly gaining traction due to their high precision in identifying pathogen DNA or RNA. Techniques such as PCR and microarrays are widely used for early detection of zoonotic infections, genetic screening, and disease surveillance.

Urinalysis
Urinalysis makes up about 7% of the technology segment. It helps in diagnosing urinary tract infections, kidney disorders, and metabolic abnormalities. The ease of sample collection and integration with point-of-care devices enhances its utility in clinical veterinary practice.

Others
The 'Others' category, contributing roughly 5%, includes cytology, endocrinology testing, and other niche diagnostic techniques. These methods are typically used in specialty veterinary centers and research applications for in-depth diagnostic evaluations.

Ambulatory Surgical Centers
*Note: Ambulatory Surgical Centers appear to be miscategorized under Technology instead of End User.* However, in relevant markets, these centers may utilize rapid diagnostics and point-of-care testing technologies to support preoperative screening and postoperative care in animals.

Animal Diagnostics Market, Segmentation by Animal Type

The Animal Diagnostics Market has been segmented by Animal Type into Farm animals - Poultry, Swine, Cattle and Others, Companion animals - Dogs, Cats, Horses and Others.

Farm Animals – Poultry
Poultry represents approximately 22% of the animal diagnostics market, driven by the need for disease prevention in high-density farming. Common diagnostics focus on avian influenza, Newcastle disease, and salmonellosis. The growing global demand for poultry meat and eggs is propelling routine health screening practices.

Farm Animals – Swine
Swine diagnostics account for around 18% of the market. Regular testing for porcine reproductive and respiratory syndrome (PRRS), swine fever, and other infectious diseases is critical for minimizing economic losses. The push for biosecurity and livestock traceability supports the demand for advanced diagnostic tools.

Farm Animals – Cattle
Cattle hold a market share of about 20%, driven by the necessity for early detection of diseases like bovine tuberculosis, mastitis, and foot-and-mouth disease. With increasing global consumption of dairy and beef products, maintaining herd health through diagnostics is a key priority for producers.

Farm Animals – Others
This segment, comprising animals such as goats, sheep, and aquaculture species, makes up around 10% of the farm animal diagnostics market. These animals are critical for regional agriculture economies, especially in developing countries where disease outbreaks significantly impact productivity.

Companion Animals – Dogs
Dogs lead the companion animal diagnostics segment, contributing approximately 15% of the overall market. Diagnostic tests commonly screen for tick-borne illnesses, parasitic infections, and chronic conditions such as diabetes and renal disease. Rising pet ownership and spending on pet care fuel demand in this category.

Companion Animals – Cats
Cats represent nearly 9% of the market, with increasing demand for diagnostic screening for feline leukemia, kidney disorders, and urinary tract infections. Indoor pet care and regular preventive checkups are driving adoption of feline-specific diagnostic panels.

Companion Animals – Horses
Horses account for roughly 4% of the companion animal diagnostics segment. Diagnostics are often used for laminitis, equine infectious anemia, and respiratory disorders. The market is supported by equine sports and breeding programs that demand high levels of health monitoring.

Companion Animals – Others
The ‘Others’ category includes small mammals, birds, and exotic pets, contributing about 2% to the total market. While niche, this segment is growing due to increased urban pet diversity and demand for species-specific diagnostic capabilities in veterinary clinics.

Animal Diagnostics Market, Segmentation by Geography

The Animal Diagnostics Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.

Animal Diagnostics Market Share (%), by Geographical Region

North America
North America leads the animal diagnostics market with a share of approximately 38%, supported by high pet ownership rates, advanced veterinary infrastructure, and increasing demand for preventive animal healthcare. The U.S. is the largest contributor due to strong research investment and widespread use of diagnostic technologies in both livestock and companion animals.

Europe
Europe accounts for nearly 27% of the market, driven by stringent animal welfare regulations, government-funded veterinary programs, and high awareness of zoonotic disease risks. Countries like Germany, the UK, and France are leading adopters of molecular diagnostics and point-of-care testing in veterinary practice.

Asia Pacific
Asia Pacific holds around 20% of the market and is expected to grow rapidly due to increasing livestock farming, pet adoption, and rising concerns over animal-borne diseases. Markets such as China, India, and Japan are investing in veterinary infrastructure and expanding access to modern diagnostics.

Middle East and Africa
The Middle East and Africa region contribute approximately 8% to the global market. The demand is rising with growing attention toward animal health monitoring in commercial farming and public health sectors. Efforts to control zoonotic outbreaks and develop veterinary laboratories are boosting diagnostics adoption.

Latin America
Latin America represents around 7% of the market, with Brazil and Mexico as key contributors. The region is witnessing steady growth due to increasing animal disease surveillance, livestock productivity initiatives, and the expansion of private veterinary clinics focused on companion animal diagnostics.

This report provides an in depth analysis of various factors that impact the dynamics of Global Animal Diagnostics Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.

Drivers, Restraints and Opportunity Analysis

Animal Diagnostics Market is becoming increasingly competitive as veterinary healthcare providers, diagnostic firms, and biotech companies expand their testing solutions. Leading players pursue strategies such as collaboration, merger, and partnerships to strengthen service networks. Nearly 65% of industry revenues are generated by established companies, ensuring consistent growth through ongoing diagnostic innovation.

Market Structure and Concentration
The market demonstrates a semi-consolidated structure, with about 55%–60% share held by major veterinary diagnostic firms. Large players dominate with wide product portfolios, while smaller participants contribute niche innovation in specialized tests. This structure fosters competitive expansion, as varied strategies align with livestock, companion animal, and research-based diagnostic needs.

Brand and Channel Strategies
Key providers implement diversified strategies, including partnerships with veterinary clinics, direct distribution to diagnostic labs, and collaboration with pharmaceutical companies. Around 45% of revenues are influenced by partnerships that improve accessibility and strengthen trust. These collaboration efforts enhance brand reputation and support steady growth across multiple animal healthcare segments.

Innovation Drivers and Technological Advancements
More than 40% of companies are investing in molecular assays, point-of-care diagnostics, and automated systems. Continuous technological advancements improve accuracy, speed, and affordability, positioning innovation as a core driver. Strategic merger agreements enhance R&D capacity, enabling faster expansion into advanced disease detection and preventive healthcare solutions.

Regional Momentum and Expansion
Nearly 50% of expansion efforts are concentrated in North America and Europe, driven by established veterinary infrastructures and rising animal healthcare awareness. Local players strengthen competitiveness through partnerships with clinics and universities, while global firms adapt strategies to regional veterinary needs. This regional momentum ensures sustained growth across diverse animal care markets.

Future Outlook
The future outlook suggests nearly 55% of industry growth will come from advanced molecular diagnostics, digital health integration, and preventive testing solutions. Companies will continue emphasizing collaboration, merger, and partnerships to expand capabilities. Ongoing technological advancements will drive further expansion, ensuring long-term competitiveness in the animal diagnostics market.

Key players in Animal Diagnostics Market include:

• IDEXX Laboratories, Inc.
• Zoetis Services LLC
• Heska Corporation
• Thermo Fisher Scientific, Inc.
• Antech Diagnostics (Mars Inc.)
• bioMérieux SA
• Neogen Corporation
• Virbac
• FUJIFILM Corporation
• Innovative Diagnostics SAS
• Indical Bioscience GmbH
• Randox Laboratories Ltd.
• Shenzhen Mindray Animal Medical Technology Co., Ltd.
• Bionote USA Inc.
• Euroimmun Medizinische Labordiagnostika AG

In this report, the profile of each market player provides following information:

• Market Share Analysis
• Company Overview and Product Portfolio
• Key Developments
• Financial Overview
• Strategies
• Company SWOT Analysis